Intra-tumoral T cells in pediatric brain tumors display clonal expansion and effector properties

Aditi Upadhye,Kevin E Meza Landeros,Ciro Ramírez-Suástegui,Benjamin J Schmiedel,Edwin Woo,Serena J Chee,Denise Malicki,Nicole G Coufal,David Gonda,Michael L Levy,Jason A Greenbaum,Grégory Seumois,John Crawford,William D Roberts,Stephen P Schoenberger,Hilde Cheroutre,Christian H Ottensmeier,Pandurangan Vijayanand,Anusha-Preethi Ganesan

DOI: https://doi.org/10.1038/s43018-023-00706-9

Abstract:Brain tumors in children are a devastating disease in a high proportion of patients. Owing to inconsistent results in clinical trials in unstratified patients, the role of immunotherapy remains unclear. We performed an in-depth survey of the single-cell transcriptomes and clonal relationship of intra-tumoral T cells from children with brain tumors. Our results demonstrate that a large fraction of T cells in the tumor tissue are clonally expanded with the potential to recognize tumor antigens. Such clonally expanded T cells display enrichment of transcripts linked to effector function, tissue residency, immune checkpoints and signatures of neoantigen-specific T cells and immunotherapy response. We identify neoantigens in pediatric brain tumors and show that neoantigen-specific T cell gene signatures are linked to better survival outcomes. Notably, among the patients in our cohort, we observe substantial heterogeneity in the degree of clonal expansion and magnitude of T cell response. Our findings suggest that characterization of intra-tumoral T cell responses may enable selection of patients for immunotherapy, an approach that requires prospective validation in clinical trials.